PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY

Premature newborns are a high risk group in terms of the infection complications growth. therefore, it is highly urgent to choose the efficient and safe antibacterial medications for the given category of patients. The authors carried out a pharma coepidemiological study of the carbapenems applicati...

Full description

Saved in:
Bibliographic Details
Main Authors: A.S. Kolbin, A.B. Ivanyuk, V.A. Lyubimenko, N.P. Shabalov
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2008-07-01
Series:Педиатрическая фармакология
Online Access:https://www.pedpharma.ru/jour/article/view/835
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849244158628200448
author A.S. Kolbin
A.B. Ivanyuk
V.A. Lyubimenko
N.P. Shabalov
author_facet A.S. Kolbin
A.B. Ivanyuk
V.A. Lyubimenko
N.P. Shabalov
author_sort A.S. Kolbin
collection DOAJ
description Premature newborns are a high risk group in terms of the infection complications growth. therefore, it is highly urgent to choose the efficient and safe antibacterial medications for the given category of patients. The authors carried out a pharma coepidemiological study of the carbapenems application among 353 newborns with very low body weight at birth, as well as the literature analysis on the use of this medications group in compliance with the evidence based medicine. As a result, they showed that for the last 8 years the frequency of the carbapenems application in Saint-Petersburg among the newborns has grown from 10 to 52%. It is statistically accurate that imipenem/cilastatin was more often used to the amount of 25 mg/kg twice a day. In 71% of cases, carbapenems were applied in the form of the empiric therapy against the general bacterial infection in combination with vancomycin and/or metronidazole. Antibiotics proved to be safe. The literature analysis showed that there is no data, which would allow one to compare the efficiency of carbapenems with other antibiotics among the newborns based on the results of the meta analyses and randomized clinical studies. Nowadays, carbapenems demonstrated high efficiency and safety in the small clinical observations.Key words: carbapenems, imipenem, meropenem, newborns with very low body weight at birth.
format Article
id doaj-art-57c03ea4147a4ebb8a9a4eecfdd024cf
institution Kabale University
issn 1727-5776
2500-3089
language Russian
publishDate 2008-07-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-57c03ea4147a4ebb8a9a4eecfdd024cf2025-08-20T03:59:16ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892008-07-01545864830PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGYA.S. Kolbin0A.B. Ivanyuk1V.A. Lyubimenko2N.P. Shabalov3Saint Petersburg State UniversitySaint Petersburg State Pediatric Medical AcademyFirst Children's City Hospital, Saint PetersburgFirst Children's City Hospital, Saint PetersburgPremature newborns are a high risk group in terms of the infection complications growth. therefore, it is highly urgent to choose the efficient and safe antibacterial medications for the given category of patients. The authors carried out a pharma coepidemiological study of the carbapenems application among 353 newborns with very low body weight at birth, as well as the literature analysis on the use of this medications group in compliance with the evidence based medicine. As a result, they showed that for the last 8 years the frequency of the carbapenems application in Saint-Petersburg among the newborns has grown from 10 to 52%. It is statistically accurate that imipenem/cilastatin was more often used to the amount of 25 mg/kg twice a day. In 71% of cases, carbapenems were applied in the form of the empiric therapy against the general bacterial infection in combination with vancomycin and/or metronidazole. Antibiotics proved to be safe. The literature analysis showed that there is no data, which would allow one to compare the efficiency of carbapenems with other antibiotics among the newborns based on the results of the meta analyses and randomized clinical studies. Nowadays, carbapenems demonstrated high efficiency and safety in the small clinical observations.Key words: carbapenems, imipenem, meropenem, newborns with very low body weight at birth.https://www.pedpharma.ru/jour/article/view/835
spellingShingle A.S. Kolbin
A.B. Ivanyuk
V.A. Lyubimenko
N.P. Shabalov
PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY
Педиатрическая фармакология
title PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY
title_full PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY
title_fullStr PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY
title_full_unstemmed PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY
title_short PHARMACOEPIDEMIOLOGY OF CARBAPENEMS APPLICATION AMONG THE PREMATURE NEWBORNS IN SAINT PETERSBURG. WORLD EXPERIENCE IN NEONATOLOGY
title_sort pharmacoepidemiology of carbapenems application among the premature newborns in saint petersburg world experience in neonatology
url https://www.pedpharma.ru/jour/article/view/835
work_keys_str_mv AT askolbin pharmacoepidemiologyofcarbapenemsapplicationamongtheprematurenewbornsinsaintpetersburgworldexperienceinneonatology
AT abivanyuk pharmacoepidemiologyofcarbapenemsapplicationamongtheprematurenewbornsinsaintpetersburgworldexperienceinneonatology
AT valyubimenko pharmacoepidemiologyofcarbapenemsapplicationamongtheprematurenewbornsinsaintpetersburgworldexperienceinneonatology
AT npshabalov pharmacoepidemiologyofcarbapenemsapplicationamongtheprematurenewbornsinsaintpetersburgworldexperienceinneonatology